Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Aktis Oncology, Inc. (AKTS) had Return on Equity of -6.52% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$3.90M |
|
$-29.94M |
|
-- |
|
$3.90M |
|
$38.65M |
|
$-34.75M |
|
$4.81M |
|
$-29.94M |
|
$-29.94M |
|
$-29.94M |
|
$-29.94M |
|
$-29.94M |
|
$-29.94M |
|
$-34.75M |
|
$-35.71M |
|
55.65M |
|
55.65M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$499.89M |
|
$15.37M |
|
$32.60M |
|
$532.48M |
|
$35.16M |
|
-- |
|
$38.45M |
|
$73.61M |
|
$458.87M |
|
$458.87M |
|
$458.87M |
|
55.78M |
|
| Cash Flow Statement Financials | |
$-70.88M |
|
$-237.99M |
|
$339.41M |
|
$38.93M |
|
$69.47M |
|
$30.54M |
|
$9.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-889.81% |
|
-889.81% |
|
-- |
|
-766.68% |
|
-766.68% |
|
$-74.77M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-6.52% |
-6.52% |
|
-5.62% |
|
-6.52% |
|
$8.23 |
|
$-1.34 |
|
$-1.27 |
|